105 related articles for article (PubMed ID: 12928723)
1. Pre-treatment mitotic index versus computer-quantitated Ki-67 nuclear antigen labeling index as predictors of response to neoadjuvant chemotherapy in uterine cervical carcinoma.
Kamoi S; Ohaki Y; Amano Y; Mori O; Matsushita N; Doi D; Okada S; Sugisaki Y; Kawamura T; Araki T
J Nippon Med Sch; 2003 Jun; 70(3):219-26. PubMed ID: 12928723
[TBL] [Abstract][Full Text] [Related]
2. Mitotic index and ki-67 nuclear antigen labeling index as predictors of chemotherapy response in uterine cervical carcinoma.
Kamoi S; Ohaki Y; Okada S; Matsushita N; Kawamura T; Araki T
Gynecol Oncol; 2001 Dec; 83(3):555-9. PubMed ID: 11733971
[TBL] [Abstract][Full Text] [Related]
3. Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas.
Horii N; Nishimura Y; Okuno Y; Kanamori S; Hiraoka M; Shimada Y; Imamura M
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):527-32. PubMed ID: 11173150
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome.
Costa S; Terzano P; Santini D; Ceccarelli C; Martoni A; Angelelli B; Panetta A; Bovicelli A; Cristiani P; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
Am J Clin Pathol; 2001 Nov; 116(5):729-37. PubMed ID: 11710691
[TBL] [Abstract][Full Text] [Related]
5. Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.
Maeda I; Abe K; Koizumi H; Nakajima C; Tajima S; Aoki H; Tsuchiya J; Tsuchiya S; Tsuchiya K; Shimo A; Tsugawa K; Ueno T; Tatsunami S; Takagi M
Breast Cancer; 2016 Sep; 23(5):745-51. PubMed ID: 26271611
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
7. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH
Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178
[TBL] [Abstract][Full Text] [Related]
8. Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Qin J; Cheng X; Chen X; Zhang X; Lu W; Xie X
Ultrasound Obstet Gynecol; 2012 Feb; 39(2):226-34. PubMed ID: 21845741
[TBL] [Abstract][Full Text] [Related]
9. Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix.
Ciolina M; Vinci V; Villani L; Gigli S; Saldari M; Panici PB; Perniola G; Laghi A; Catalano C; Manganaro L
Radiol Med; 2019 Oct; 124(10):955-964. PubMed ID: 31254220
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
11. [Usefulness of MR imaging in evaluating and predicting effect of neoadjuvant chemotherapy on uterine cervical carcinoma].
Amano M; Kato T
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Mar; 57(4):176-81. PubMed ID: 9125873
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.
Qin T; Zhen J; Zhou M; Wu H; Ren R; Qu B; Wang H
Int J Surg; 2016 Jun; 30():121-5. PubMed ID: 27131759
[TBL] [Abstract][Full Text] [Related]
13. Nuclear morphometry as a predictor of response to neoadjuvant chemotherapy plus radiotherapy in locally advanced cervical cancer.
Yacoub SF; Shaeffer J; el-Mahdi AM; Faris L; Zhu A
Gynecol Oncol; 1994 Sep; 54(3):327-32. PubMed ID: 8088609
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
16. [Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
CHEN XD; SHI HY; LÜ WG; QIN JL
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):173-6. PubMed ID: 21575388
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
[TBL] [Abstract][Full Text] [Related]
18. Control of cell proliferation kinetics of tumor in neoadjuvant chemotherapy for advanced oral squamous cell carcinoma and its prognostic implications.
Noguchi M; Kinjyo H; Miyazaki A; Kubota H; Kohama G
Int J Clin Oncol; 2002 Jun; 7(3):138-44. PubMed ID: 12109514
[TBL] [Abstract][Full Text] [Related]
19. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]